Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Combination Therapy for Age-Related Macular Degeneration.
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
- Status
- UNKNOWN
- Phase
- PHASE3
Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE3
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2